Skip to main content
Patient portrayal of a man

A Patient Navigator can help be your guide to starting SCEMBLIX

The Novartis Patient Navigator Program is staffed by a team of specialists who are available to support you during your treatment journey.* Once enrolled in the program, you will receive a series of phone calls from a specially trained navigator who will support and guide you through various aspects of initiating your prescribed medicine.

Novartis Patient Navigators:

  • Educate on product attributes: for example, dosing and administration, side effects, and monitoring recommendations

  • Provide information on lifestyle support during treatment

  • Educate on the benefits investigation process: review the results and out-of-pocket responsibilities

  • Provide access to disease education materials and guide patients to other Novartis resources where applicable

Novartis Patient Navigator Program: To learn more about the Patient Navigator Program, contact Patient Assistance Now Oncology (PANO) at 1-800-282-7630, prompt 3

To enroll in the Patient Navigator Program, simply complete and submit the form below or contact Patient Assistance Now Oncology (PANO) at 1‑800‑282‑7630, prompt 3.
*The Novartis Patient Navigator Program is available for select Novartis Oncology products. Patient Navigator services do not involve the practice of nursing or provide clinical advice and counseling.
Must be prescribed a Novartis Oncology medicine for an approved indication that is offered within the Patient Navigator Program.

Enroll in the Novartis Patient Navigator Program

To sign up for SCEMBLIX Patient Navigator, please fill out the form below, and then click "Submit" when you're finished. You must be 18 years of age or older to participate in this program.

* Required fields.
Gender *
Select a State
By checking this box, I confirm that I am taking SCEMBLIX for an approved use, consistent with the product's Prescribing Information. See below for approved uses.
I agree to the Terms & Conditions: You consent to receive marketing calls and texts from and on behalf of Novartis Pharmaceuticals Corporation, made with an autodialer or prerecorded voice, at the phone number(s) provided. You understand that your consent is not required or a condition of purchase. Number of messages will vary based on your program selections; average of [3 to 15] messages per week. Message and data rates may apply. The Novartis Pharmaceuticals Corporation Privacy Policy is available at Text STOP to opt out and HELP for help.
OK to leave detailed voice mail about your medication on your phone *
Type of Insurance *

By clicking submit, I confirm I’d like to enroll in the Patient Navigator Program, and agree to receive recurring phone calls from a Novartis Patient Navigator at the number(s) provided. Calls may be prerecorded or autodialed. Consent and participation in the Program is not a condition of purchase of a product or service.

Thank you for signing up for the Novartis Patient Navigator Program.

Thank you for registering. A Navigator will be contacting you to confirm your eligibility.

Important Safety Information

Before taking SCEMBLIX, tell your doctor about all your medical conditions, including if you:

  • have a history of inflammation of your pancreas (pancreatitis)
  • have a history of heart problems or blood clots in your arteries and veins (types of blood vessels)
  • are pregnant or plan to become pregnant. SCEMBLIX can harm your unborn baby ...

Approved Uses

SCEMBLIX is a prescription medicine used to treat adults with:

  • Philadelphia chromosome–positive chronic myeloid leukemia (Ph+ CML) in chronic phase (CP), previously treated with 2 or more tyrosine kinase inhibitors (TKIs)
  • Ph+ CML in CP with the T315I mutation ...